Prostate Cancer - Results from #27220

A novel indium-111-labeled gonadotropin-releasing hormone peptide for human prostate cancer imaging - Abstract September 1, 2011

Use of Surveillance, Epidemiology, and End Results-Medicare data to conduct case-control studies of cancer among the US elderly - Abstract September 1, 2011

Prevalence and correlates of vitamin and supplement usage among men with a family history of prostate cancer - Abstract September 1, 2011

Sunitinib in combination with docetaxel and prednisone in chemotherapy-naive patients with metastatic, castration-resistant prostate cancer: A phase 1/2 clinical trial - Abstract September 1, 2011

The role of C-choline-PET/CT-guided secondary lymphadenectomy in patients with PSA failure after radical prostatectomy: Lessons learned from eight cases - Abstract September 1, 2011

Usefulness of postoperative nadir prostate-specific antigen value by ultrasensitive assay as a predictor of prostate-specific antigen relapse for pathological T3 or positive surgical margins after radical prostatectomy for prostate cancer - Abstract September 1, 2011

Editor's Commentary - Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer September 1, 2011

Editor's Commentary - Projecting the clinical benefits of adjuvant radiotherapy versus observation and selective salvage radiotherapy after radical prostatectomy: A decision analysis September 1, 2011

3-D fiducial motion tracking using limited MV projections in arc therapy - Abstract August 31, 2011

Peritoneal dissemination of prostate cancer due to laparoscopic radical prostatectomy: A case report - Abstract August 31, 2011

Post-translational modification of the androgen receptor - Abstract August 31, 2011

Perineural invasion predicts increased recurrence, metastasis, and death from prostate cancer following treatment with dose-escalated radiation therapy - Abstract August 31, 2011

Higher percentage of positive biopsy cores and Gleason score are associated with a greater degree of prostate gland shrinkage after neoadjuvant cytoreductive therapy - Abstract August 31, 2011

Prostate cancer gene 3 score predicts prostate biopsy outcome in men receiving dutasteride for prevention of prostate cancer: Results from the REDUCE trial - Abstract August 31, 2011

The optimal rebiopsy prostatic scheme depends on patient clinical characteristics: Results of a recursive partitioning analysis based on a 24-core systematic scheme - Abstract August 31, 2011

Editor's Commentary - Impact of race on biochemical disease recurrence after prostate brachytherapy August 31, 2011

Use of machine learning methods for prediction of acute toxicity in organs at risk following prostate radiotherapy - Abstract August 30, 2011

Automated prostate cancer localization without the need for peripheral zone extraction using multiparametric MRI - Abstract August 30, 2011

Real-time elastography in the detection of prostate cancer in patients with raised PSA level - Abstract August 30, 2011

Impact of immediate TRUS rebiopsy in a patient cohort considering active surveillance for favorable risk prostate cancer - Abstract August 30, 2011

Page 1362 of 1436